Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-002435
Filing Date
2022-08-12
Accepted
2022-08-12 17:12:50
Documents
93
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220630x10q.htm   iXBRL 10-Q 1937759
2 EX-31.1 tmb-20220630xex31d1.htm EX-31.1 12965
3 EX-31.2 tmb-20220630xex31d2.htm EX-31.2 12858
4 EX-32 tmb-20220630xex32.htm EX-32 9855
  Complete submission text file 0001410578-22-002435.txt   8864756

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20220630.xsd EX-101.SCH 83650
6 EX-101.CAL tmb-20220630_cal.xml EX-101.CAL 62639
7 EX-101.DEF tmb-20220630_def.xml EX-101.DEF 203195
8 EX-101.LAB tmb-20220630_lab.xml EX-101.LAB 550479
9 EX-101.PRE tmb-20220630_pre.xml EX-101.PRE 415391
87 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220630x10q_htm.xml XML 1734785
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39752 | Film No.: 221161189
SIC: 2834 Pharmaceutical Preparations